SCHEDULE 13G 0001912606 XXXXXXXX LIVE Common Stock 09/04/2025 0001339005 Femasys, Inc. 31447E105 601 Brickell Key Dr. Suite 700 Miami FL 33131 Rule 13d-1(c) Alumni Capital LP DE 0.00 4773579.00 0.00 4773579.00 4773579.00 Y 9.99 PN Alumni Capital GP LLC X1 0.00 4773579.00 0.00 4773579.00 4773579.00 Y 9.99 OO Ashkan Mapar X1 0.00 4773579.00 0.00 4773579.00 4773579.00 Y 9.99 IN Femasys, Inc. 3950 Johns Creek Court, Suite 100 Suwanee, GA 30024 This statement is filed by Alumni Capital LP (the "Fund"), Alumni Capital GP LLC (the "General Partner"), and Ashkan Mapar (the "Controlling Person"). The foregoing are collectively referred to herein as the "Reporting Persons". The Fund holds, has the right to acquire, or has the obligation to acquire, securities of the Issuer. The General Partner serves as the general partner of the Fund. The Controlling person is the control person of the General Partner. The address for the principal business office of each of Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar is 601 Brickell Key Dr., Suite 700, Miami, FL 33131. Alumni Capital LP is a Delaware limited partnership. Alumni Capital GP LLC is a Delaware limited liability company. Ashkan Mapar is a citizen of the United States of America. Y Alumni Capital LP - 4,773,579* Alumni Capital GP LLC - 4,773,579* Ashkan Mapar - 4,773,579* *The shares of common stock (the "Shares") of Femasys, Inc. (the "Issuer") reported herein represent Shares that may be acquired by Alumni Capital LP (the "Fund") pursuant to (i) a Purchase Agreement dated June 30, 2025, between the Issuer and the Fund (the "Purchase Agreement"), (ii) a warrant to purchase common stock dated August 27, 2025 of the Issuer held by the Fund (the "Common Warrant"), and (iii) a pre-funded warrant to purchase common stock dated August 27, 2025 of the Issuer held by the Fund (the "Pre-Funded Warrant"). Under the Common Warrants and Pre-Funded Warrants, the Fund may acquire Shares (or securities convertible into or exercisable for Shares) in accordance with the respective terms and subject to the respective conditions and limitations contained therein. One of such limitations is that the Fund is prohibited from acquiring any Shares under the Common Warrants and Pre-Funded Warrants, which, when aggregated with all other Shares then beneficially owned by the Fund and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.99% of the Shares outstanding (the "Warrant Ownership Limitation"). The Fund may increase the Warrant Ownership Limitation up to 9.99% (a) upon sixty-one (61) days prior written notice to the Issuer, or (b) upon written agreement of the Fund and the Issuer. Furthermore, under the Purchase Agreement, at the Issuer's sole discretion, the Fund may be required to purchase Shares, in accordance with the terms and subject to the conditions and limitations of the Purchase Agreement. One of such limitations is that the Fund is prohibited from acquiring any Shares under the Purchase Agreement, which, when aggregated with all other Shares then beneficially owned by the Fund and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.99% of the Shares outstanding (the "Purchase Agreement Ownership Limitation"). The Fund may increase the Purchase Agreement Ownership Limitation up to 9.99% (a) upon written notice to the Issuer, or (b) upon written agreement of the Fund and the Issuer. As such, the percent of class reported herein is giving effect to the Warrant Ownership Limitation and the Purchase Agreement Ownership Limitation as if either was increased to 9.99%, and it is based upon the Issuer's representation to the Fund on August 27, 2025 that there were 43,009,993 Shares outstanding as of August 27, 2025 plus the approximate total number of Shares that the Reporting Persons may acquire at the direction of the Issuer and/or upon exercise of all Common Warrants and Pre-Funded Warrants (subject to the Warrant Ownership Limitation or the Purchase Agreement Ownership Limitation as if either was increased to 9.99%) in accordance with Rule 13d-3(d)(1)(i) under the Act. For the sake of clarity, the Fund owns 931,900 Shares as of the date of the filing, has the right to acquire 1,327,018 Shares upon exercise of outstanding Common Warrants and Pre-Funded Warrants as of the date of the filing (based on the Warrant Ownership Limitation and Purchase Agreement Ownership Limitation), and is electing to file this Schedule 13G solely to the extent that, for the purposes of Section 240.13d-3, the Reporting Persons are deemed to beneficially own the Shares pursuant to the Purchase Agreement, the Common Warrants, and the Pre-Funded Warrants. The filing of this report shall not be deemed an admission, for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of such Reporting Person's pecuniary interest, if any, therein. 9.99 % (3) Alumni Capital LP - 0 Alumni Capital GP LLC - 0 Ashkan Mapar - 0 Alumni Capital LP - 4,773,579* Alumni Capital GP LLC - 4,773,579* Ashkan Mapar - 4,773,579* Alumni Capital LP - 0 Alumni Capital GP LLC - 0 Ashkan Mapar - 0 Alumni Capital LP - 4,773,579* Alumni Capital GP LLC - 4,773,579* Ashkan Mapar - 4,773,579* Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. A. Agreement of Joint Filing Alumni Capital LP /s/ Ashkan Mapar 09/04/2025 Alumni Capital GP LLC /s/ Ashkan Mapar 09/04/2025 Ashkan Mapar /s/ Ashkan Mapar 09/04/2025